Results 51 to 60 of about 41,066 (212)
Pathology of Hereditary Breast and Ovarian Cancer
Frontiers in Oncology, 2020 Hereditary breast and ovarian cancer (HBOC) syndrome is most commonly characterized by deleterious germline mutations in BRCA1 and BRCA2. HBOC patients are prone to the development of malignant neoplasms in multiple organs including the breast, ovary ...
Anjelica Hodgson +2 more
doaj +1 more source
Paratubal serous borderline tumor in an 85 years old woman: A case report [PDF]
, 2020 Paratubal cysts are incidental, common and benign lesions with few cases of borderline tumor and adenocarcinoma been reported in the literature. Herein, we are discussing a case of an 85 years old woman who visited her Obstetrics and Gynecologist for a ...
El Helou, Nicole +3 more
core +1 more source
Afatinib use in recurrent epithelial ovarian carcinoma. [PDF]
, 2019 •Genomic tumor testing is an important tool in guiding treatment for gynecologic malignancies.•Targetable mutations may lead to new therapies in gynecologic cancer treatment.•Her2/neu mutations in serous ovarian carcinomas can be targeted with ERBB2 ...
Alvarez, Edwin A +3 more
core +1 more source
Serous cystadenocarcinoma of the spleen
Radiology Case Reports, 2017 The commonly seen primary malignant neoplasms of the spleen are angiosarcoma and lymphoma. We present a case of serous cystadenocarcinoma of the spleen.
Chung Kuao Chou, MD, Shih-Cheng Chou, MD
doaj +1 more source
Hereditary ovarian cancer [PDF]
, 2009 Apoptosis is a form of cell death that permits the removal of damaged, senescent or unwanted cells in multicellular organisms, without damage to the cellular microenvironment.
BAZAN, Viviana +5 more
core +1 more source
Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis [PDF]
, 2012 Familial adenomatous polyposis (FAP) is an autosomal dominant cancer predisposition syndrome that accounts for approximately 0.5–1% of all colorectal cancer cases.
Abraham +36 more
core +1 more source
Role of frozen section in surgical management of ovarian neoplasm
Gynecology and Minimally Invasive Therapy, 2020 Objective: Cancers of the adnexae, including ovarian and fallopian tube, constitute the eighth most common cancers among women worldwide. Surgery remains the cornerstone in the management of ovarian cancer.
Saphina Palakkan +4 more
doaj +1 more source
TGFβ controls ovarian cancer cell proliferation [PDF]
, 2018 There have been no major improvements in the overall survival of ovarian cancer patients in recent decades. Even though more accurate surgery and more effective treatments are available, the mortality rate remains high.
Alsina Sanchís, Elisenda +11 more
core +1 more source
Paclitaxel (Taxol) in relapsed and refractory ovarian cancer: the UK and Eire experience [PDF]
, 1995 The purpose of our study was to investigate the efficacy and toxicity of paclitaxel in patients with relapsed or refractory epithelial ovarian cancer in the context of a large multicentre study performed in the UK and Eire.
Perren, TJ
core +1 more source
Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment [PDF]
, 2016 Background: Despite standard treatment for epithelial ovarian cancer (EOC), that involves cytoreductive surgery followed by platinum-based chemotherapy, and initial high response rates to these, up to 80 % of patients experience relapses with a median ...
Caruso, Davide +4 more
core +2 more sources